Strüngmann Brothers invest in eHealth Specialist ICW

InterComponentWare AG (ICW)Santo Holding (Germany) GmbH of Hexal founders Strüngmann secured a 25 percent share in the eHealth specialist InterComponentWare AG (ICW). This transaction was performed by the purchase of newly issued shares in the context of an increase in capital stock. The present owners of ICW do not surrender any shares in this transaction.

ICW will invest its newly acquired funds into the further expansion of its leading position in the international eHealth market. The company is one of the internationally active eHealth pioneers and offers a very broad range of solutions focusing on citizens respectively patients.

ICW pursues two strategic approaches to improve communication and thus also quality and efficiency in the health care system: First of all, it supports the introduction of ubiquitous secure health care IT infrastructures with electronic health cards and personal health records. At the beginning of 2007, ICW was awarded the pilot project for the introduction of the national electronic health card in Bulgaria. The company also conducts a field test for the electronic health card in Germany since 2005, which includes the personal health record LifeSensor. The LifeSensor technology is also applied in the BARMER research project, in which Germany's largest health insurance company will offer its approx. 7 million insurants a personal health record.

ICW's second strategic approach is to network medical professionals in medical practices and hospitals with each other. PPV, for example, a Bavarian physician's network, uses ICW solutions to give its approximately 350 members a comprehensive view of their patients' medical data. Heidelberg University Hospital also opted for a solution developed by ICW to network with its partner hospitals. This solution also incorporates patients and resident physicians into the improved data flow.

"The trust of our new investors in ICW shows that we are pursuing the right strategy and that our solutions have a large national and international market potential", explains ICW's CEO Peter Reuschel. The Strüngmann brothers are also absolutely convinced that ICW will continue to expand its position in the global eHealth market: "We opted for an investment in ICW, because it is in a perfect position to assert itself in the high-growth global eHealth market with its open platform approach and mature solutions. With its networking solutions, ICW has the potential to make the national and global health care market more efficient. We want to support and accompany this process", explain the Strüngmann brothers.

Related news articles:

About InterComponentWare
InterComponentWare AG (ICW) is a leading international eHealth specialist with locations in Germany, the United States, Austria, Switzerland and Bulgaria. Its solutions for networking the various players in the healthcare system lastingly improve process-oriented communication and data integrity, and therefore also the quality of healthcare. Among other things, ICW develops and distributes software and hardware components for the healthcare IT infrastructure for electronic health cards, the LifeSensor personal health record as well as networking solutions for hospitals and physician offices. As part of the bIT4health consortium, ICW provided important consulting services for the implementation of the electronic health card in Germany, is involved in the Austrian eCard project and has won the pilot project for the national health card in Bulgaria. For further information, visit:

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...